High Dose Insulin Therapy for Patients with T2DM and Severe Insulin Resistance:
Comprehensive Clinical Update and Expert Recommendations

Lawrence Blonde, MD; Wendy Lane, MD; Jay Skyler, MD

Supported by an educational grant from Eli Lilly and Company

Advances in the Clinical Management of Obesity:
Implications of Therapies in Late-Stage Development

Caroline Apovian, MD; Louis Aronne, MD; Kenneth Fujioka, MD

Supported by an educational grant from Orexigen Therapeutics, Inc.

Advances in Dual Anti-Platelet Therapy:
Optimizing Anti-Thrombotic Therapy in Patients with ACS

Jeffrey Anderson, MD; Christopher Cannon, MD; Marc Sabatine, MD

Supported by an educational grant from Daiichi Sankyo, Inc.
and Eli Lilly and Company

Targeting the Endothelin Pathway: Novel Strategies to Delay Disease Progression and Improve Outcomes in Pulmonary Arterial Hypertension

Michael Landzberg, MD; Ioana Preston, MD; Jeffrey Sager, MD

Supported by an educational grant from Actelion Pharmaceuticals US, Inc.

New Treatment Paradigms for Comprehensive Cardiometabolic Risk Reduction:
The Role of GLP-1 Receptor Agonists in the Management of T2DM, Obesity, Hypertension and Dyslipidemia

Ralph DeFronzo, MD; David Kendall, MD; Anne Peters, MD

Supported by an educational grant from Amylin/Lilly

Clinical Dilemmas in Managing the Hypertensive Patient with Osteoarthritis

Michael Farkouh, MD; Alan Gradman, MD; R. Preston Mason, PhD; William White, MD

Supported by an educational grant from NicOx, Inc.